"pseudodeficiency" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "pseudo",
        "3": "deficiency"
      },
      "expansion": "pseudo- + deficiency",
      "name": "prefix"
    }
  ],
  "etymology_text": "pseudo- + deficiency",
  "forms": [
    {
      "form": "pseudodeficiencies",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {
        "1": "~"
      },
      "expansion": "pseudodeficiency (countable and uncountable, plural pseudodeficiencies)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with pseudo-",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 August 7, Alexander A. Boucher et al., “Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report”, in Orphanet Journal of Rare Diseases, volume 10, →DOI",
          "text": "Exclusion of other rare demyelinating disorders (with coincidental ARSA pseudodeficiency carriage) is typically achieved by the demonstration of hyper-excretion of accumulating substrate (urine sulfatide assessment), pathognomonic histopathology on nervous tissue biopsy, or/and presence of causative ARSA mutations on molecular analysis.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "An apparent deficiency"
      ],
      "id": "en-pseudodeficiency-en-noun-Q5wumP1x",
      "links": [
        [
          "deficiency",
          "deficiency"
        ]
      ],
      "tags": [
        "countable",
        "uncountable"
      ]
    }
  ],
  "word": "pseudodeficiency"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "pseudo",
        "3": "deficiency"
      },
      "expansion": "pseudo- + deficiency",
      "name": "prefix"
    }
  ],
  "etymology_text": "pseudo- + deficiency",
  "forms": [
    {
      "form": "pseudodeficiencies",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {
        "1": "~"
      },
      "expansion": "pseudodeficiency (countable and uncountable, plural pseudodeficiencies)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English countable nouns",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with pseudo-",
        "English terms with quotations",
        "English uncountable nouns"
      ],
      "examples": [
        {
          "ref": "2015 August 7, Alexander A. Boucher et al., “Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report”, in Orphanet Journal of Rare Diseases, volume 10, →DOI",
          "text": "Exclusion of other rare demyelinating disorders (with coincidental ARSA pseudodeficiency carriage) is typically achieved by the demonstration of hyper-excretion of accumulating substrate (urine sulfatide assessment), pathognomonic histopathology on nervous tissue biopsy, or/and presence of causative ARSA mutations on molecular analysis.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "An apparent deficiency"
      ],
      "links": [
        [
          "deficiency",
          "deficiency"
        ]
      ],
      "tags": [
        "countable",
        "uncountable"
      ]
    }
  ],
  "word": "pseudodeficiency"
}